BioSpace News Archive

ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants

The Options are exercisable on or before October 4, 2029 at the price of US$3.23 per Common share and are granted in accordance with the polices of the TSX Venture Exchange and the terms and conditions of the Existing Option Plan.

October 7, 2019
·
9 min read
Policy

Amyris Files Form 10-Qs to Achieve Compliance - Notes Receipt of Nasdaq Deficiency Notification

The company also noted that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed these quarterly reports on Form 10-Q in accordance with the required September 30 deadline

October 7, 2019
·
1 min read
Renewal of Agreement to Establish a Funding Framework and Funding Rules for the Cree Board of Health and Social Services of James Bay for the period 2019-2024

This is the third five-year agreement and funding framework for the Cree Health Board entered into with the Government of Quebec.

October 7, 2019
·
2 min read
Pharm Country

PanOptica to Present Positive Topical Anti-VEGF Eye Drop Data at OIS@AAO

PAN-90806 is a once-daily topical formulation of a small-molecule anti-vascular endothelial growth factor eye drop for the treatment of neovascular eye diseases, including neovascular age-related macular degeneration

October 7, 2019
·
2 min read
Business

QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Partnership to accelerate the adoption of next-generation sequencing (NGS) in clinical decision-making

October 7, 2019
·
2 min read
Job Trends

vertX Bioprocess Conference Convenes Biotech and Biopharma Leaders to Accelerate Industry Collaboration

Thermo Fisher Scientific’s forum focuses on strategies to expedite biotherapeutic development and commercialization

October 7, 2019
·
2 min read
Policy

ACB Applauds Supreme Court Decision to Decline Appeal on Domino’s v. Robles Case

ADA Applies to Websites

October 7, 2019
·
2 min read
BioMidwest

SHINE closes $50-million financing with Oaktree to support execution of construction and commercialization plans

The financing supports the ongoing construction of SHINE’s medical isotope production facility and its commercialization of diagnostic and therapeutic isotopes, including molybdenum-99 (Mo-99) and lutetium-177

October 7, 2019
·
4 min read
BioMidwest

GEHA Expands Health and Well-being Benefits and Services, Offers Two New Nationwide Benefit Plans to FEHB Program Members

Addition of Elevate and Elevate Plus Bring Total GEHA FEHB Plan Offerings to Five

October 7, 2019
·
3 min read
Biotech Beach

Featured Speaker Dr. Daniel Amen to Discuss His Book The End of Mental Illness at National Talking About Curing Autism (TACA) West Coast Conference

Dr. Amen will address how neuroscience is disrupting psychiatry and helping to prevent or reverse mental health issues

October 7, 2019
·
1 min read